Sinonasal Adenoid Cystic Carcinoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2026-04-13
Clinical Trial Update: A Study of Becotatug Vedotin (MRG003) Combined With Epirubicin as Neoadjuvant Therapy for EGFR-Positive, Unresectable Recurrent Sinonasal Adenoid Cystic Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating Becotatug Vedotin (MRG003) with Epirubicin as neoadjuvant therapy for EGFR-positive, unresectable recurr…